Loading...
XNYS
GRDN
Market cap2.60bUSD
Jul 09, Last price  
41.06USD
1D
1.66%
1Q
4.88%
IPO
131.32%
Name

Guardian Pharmacy Services Inc

Chart & Performance

D1W1MN
XNYS:GRDN chart
P/E
52.80
P/S
1.79
EPS
0.78
Div Yield, %
Shrs. gr., 5y
0.79%
Rev. gr., 5y
14.50%
Revenues
1.45b
+17.93%
600,365,000698,287,000735,958,000792,072,000908,909,0001,046,193,0001,228,409,0001,448,685,000
Net income
49m
P
14,678,00021,745,00019,943,00016,314,00035,421,00023,902,000-87,287,00049,219,000
CFO
100m
+73.04%
43,675,00056,160,00052,611,00058,498,00048,522,00070,819,00057,960,000100,293,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
IPO date
Sep 26, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT